118 SRES 775 IS: Expressing support for the designation of July 15, 2024, as “National Leiomyosarcoma Awareness Day”. U.S. Senate 2024-07-30 text/xml EN Pursuant to Title 17 Section 105 of the United States Code, this file is not subject to copyright protection and is in the public domain.

III118th CONGRESS2d SessionS. RES. 775IN THE SENATE OF THE UNITED STATESJuly 30, 2024Ms. Stabenow submitted the following resolution; which was referred to the Committee on Health, Education, Labor, and PensionsRESOLUTIONExpressing support for the designation of July 15, 2024, as “National Leiomyosarcoma Awareness Day”.

Whereas leiomyosarcoma is a malignant sarcoma subtype, 1 of 70 to 100 such subtypes, that arises in smooth muscle and has several subtypes itself due to its vascularity and bone invasion;Whereas leiomyosarcoma is designated by the National Institutes of Health as a rare form of cancer;Whereas leiomyosarcoma is largely resistant to standard chemotherapy treatments, radiation treatments, and immunotherapy trials, with 40-year-old chemotherapy treatments still in use;Whereas leiomyosarcoma affects all age groups, including children, young adults, the middle-aged, and the elderly, and all genders;Whereas leiomyosarcoma is diagnosed in more than 2,000 individuals in the United States each year;Whereas, with respect to leiomyosarcoma, research and clinical trials remain complicated and extremely costly due to the difficulty of recruiting patients;Whereas survival and longevity for individuals with leiomyosarcoma has not significantly improved for at least 30 years;Whereas multidisciplinary care coordination teams, because of their expertise and experience, are critical to the health of leiomyosarcoma patients;Whereas researchers continue to strive to improve quality of life for leiomyosarcoma patients, improve outcomes in clinical trials, and promote enhanced survivorship; andWhereas increased education and awareness about sarcoma and leiomyosarcoma will contribute to the well-being of the communities of the United States: Now, therefore, be it

That the Senate—(1)supports the designation of July 15, 2024, as National Leiomyosarcoma Awareness Day;(2)recognizes the challenges faced by leiomyosarcoma patients; and(3)commends the dedication of organizations, volunteers, researchers, and caregivers across the United States working to improve the quality of life of leiomyosarcoma patients and their families.